Dolly the sheep, the first cloned mammal, sparked global fascination three decades ago.While initial hype predicted a sci-fi future of cloned pets, humans, and resurrected extinct species, cloning has evolved into a complex biotechnology tool.Today, it aids disease research, conservation efforts, and regenerative medicine through techniques like somatic cell nuclear transfer.However, challenges persist: cloning remains inefficient, requiring specialized equipment and facing epigenetic reprogramming hurdles.Despite these difficulties, applications include replicating livestock with desirable traits, pet cloning, and endangered species preservation.Ethical debates loom over human cloning, animal welfare concerns in de-extinction projects, and the ecological impact of resurrected species.Australia now allows horse cloning, while China and the U.S.offer pet cloning services.

The article highlights cloning's dual role as both a scientific breakthrough and a contentious ethical issue, emphasizing its potential to reshape biology without replacing traditional methods.